Company / Total Assets
Cytek Biosciences, Inc. Total Assets History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$461.5M
FY2025
5-year range
$461.5M / $519.5M
FY2021-FY2025
Trend
-7.6%
vs FY2024
Sector context
#140 of 161
Health Care
What the data says
Cytek Biosciences, Inc.'s total assets of $462M is lower than 87% of companies in the Health Care sector (FY2025). Total Assets has fluctuated over the past 6 years, ranging from $220M in FY2020 to $519M in FY2022.
Based on SEC 10-K filings.
$462M in FY2025 with a 5-year CAGR of +16.0%.
Declined from $494M to $462M over the past 2 years.
Health Care sector context is included.
Total Assets over time
Growth rates
- 3-Year CAGR
- -3.9%
- 5-Year CAGR
- +16.0%
- 10-Year CAGR
- -
Sector benchmark
Bottom 13% in Health CareTop 87% of 161This company $461.5M Sector average $14.8B
▼
-96.9% below sector average
Key checks
Key Insights
- 5-year CAGR of +16.0%, indicating consistent growth.
- In FY2025, total assets decreased 7.6% year-over-year.
- Ranks #140 out of 161 companies in the Health Care sector.
- Peak total assets was recorded in FY2022.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $461.5M | -7.6% |
| FY2024 | $499.5M | +1.0% |
| FY2023 | $494.5M | -4.8% |
| FY2022 | $519.5M | +12.1% |
| FY2021 | $463.3M | +110.6% |
| FY2020 | $220.0M | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026